Succinate dehydrogenase (SDHB, SDHC, and SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma
Succinate dehydrogenase (SDHB, SDHC, and SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma. // Genetics in Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1098360026010439?dgcid=rss_sd_all
Succinate dehydrogenase (SDHB, SDHC, and SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma. Genetics in Medicine. https://www.sciencedirect.com/science/article/pii/S1098360026010439?dgcid=rss_sd_all
“Succinate dehydrogenase (SDHB, SDHC, and SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma.” Genetics in Medicine.
@article{article46744,
title = {Succinate dehydrogenase (SDHB, SDHC, and SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma},
journal = {Genetics in Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1098360026010439?dgcid=rss_sd_all}
}